Vaccines for recurrent respiratory papillomatosis and methods of using the same
US11744885B2 · kind B2 · utility
0Cited by
27References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2021 |
| Grant date | Sep 5, 2023 |
| Priority date | — |
| Expiry date | Nov 9, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20071
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are nucleic acid molecules encoding an HPV antigen. Also provided are vaccines against human papillomavirus (HPV) comprising the nucleic acids, methods of inducing immune responses, and methods for prophylactically and/or therapeutically immunizing individuals against recurrent respiratory papillomatosis (RRP). Pharmaceutical compositions, recombinant vaccines comprising DNA plasmid and live attenuated vaccines are disclosed as well as methods of inducing an immune response to treat or prevent RRP are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.